XORTX Therapeutics Inc. (XRTX) stock
XRTXNasdaqPharmaceutical PreparationsFiscal year ends December 31
$1.06+0.00 (0.00%)
Close on Nov 18, 2026Market cap $116.17KP/E –Yield –
XORTX Therapeutics shares outstanding
Diluted shares outstanding: the weighted share count used for earnings per share, adjusted for stock splits.
For fiscal 2025 it was 5M, up 64.5% from the year before. The highest annual figure on record is 5M in fiscal 2025.
Annual shares outstanding
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 5M | +64.5% |
| FY2024 | Dec 31, 2024 | 3M | +45.3% |
| FY2023 | Dec 31, 2023 | 2M | +33.9% |
| FY2022 | Dec 31, 2022 | 1M | +35.3% |
| FY2021 | Dec 31, 2021 | 1M | – |
See a number that looks wrong?